
Impact of Inflation Reduction Act on Orphan Drug Development
Article Summary – President Biden signed the Inflation Reduction Act (IRA) in 2022, targeting reduction in health care costs by mandating price reductions for some expensive Medicare/Medicaid drugs, excluding orphan drugs with a single indication. The Act may, however, lead to unintended consequences in the orphan drug market, as it










